Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2012

View Archived Issues

Liposomal irinotecan shows benefit in metastatic colorectal cancer

Risk loci for multiple myeloma identified

Phase IIa trial assesses daclatasvir/asunaprevir in difficult-to-treat hepatitis C

BioLineRx signs license agreement with Genoscience

Cephalon scientists disclose synthesis, pharmacological and first clinical data on CEP-11981

Novel polypeptides prepared by Zealand Pharma

Novel phosphodiesterase 10A inhibitors synthesized in Japan

New phosphodiesterase 4 inhibitors presented by Leo Pharma

Abbott profiles pipeline progress of 2011

German team patents new agents with neurogenic and neurotrophic properties

Recruitment begins in phase Ib/II U3-1287 combination study

Vertex Pharmaceuticals patents new serine/threonine-protein kinase ATR inhibitors

Merck & Co. designs new protein kinase inhibitors

RPCI launches first-ever trial of dendritic vaccine plus rapamycin

Celgene announces merger agreement

EMA grants orphan drug status to Celator product

Biogen Idec and Elan evaluate Tysabri in secondary progressive MS

Auxilium Pharmaceuticals doses first patients in Xiaflex study

Studies detail beta-amyloid detection with florbetapir F 18 PET

Kancera subsidiary and Agios Pharmaceuticals launch alliance

Lpath suspends dosing in clinical studies of iSONEP

BioAlliance Pharma outlines major achievements of 2011 and prospects for 2012

Enrollment begins in Japan in phase III trials of orteronel

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...